Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
18.78
+2.92 (18.41%)
At close: Mar 6, 2026, 4:00 PM EST
18.67
-0.11 (-0.59%)
After-hours: Mar 6, 2026, 7:54 PM EST
Biodesix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 88.5 | 71.32 | 49.09 | 38.21 | 54.51 | |
| Revenue Growth (YoY) | 24.08% | 45.30% | 28.46% | -29.89% | 19.64% | |
| Cost of Revenue | 16.72 | 15.57 | 13.01 | 14.15 | 30.52 | |
| Gross Profit | 71.78 | 55.75 | 36.08 | 24.06 | 23.99 | |
| Selling, General & Admin | 87.55 | 80.45 | 67.39 | 61.46 | 50.52 | |
| Research & Development | 12 | 9.56 | 9.99 | 13.1 | 12.79 | |
| Operating Expenses | 99.55 | 90.01 | 77.38 | 74.56 | 63.31 | |
| Operating Income | -27.77 | -34.26 | -41.3 | -50.51 | -39.32 | |
| Interest Expense | -7.72 | -8.26 | -9.54 | -8.07 | -4.51 | |
| Other Non Operating Income (Expenses) | 0.32 | 0.07 | -1.27 | 0.19 | -0.01 | |
| EBT Excluding Unusual Items | -35.16 | -42.45 | -52.1 | -58.39 | -43.84 | |
| Asset Writedown | -0.11 | -0.24 | -0.04 | -0.08 | - | |
| Other Unusual Items | - | -0.25 | - | -6.98 | 0.68 | |
| Pretax Income | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 | |
| Net Income | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 | |
| Net Income to Common | -35.27 | -42.93 | -52.15 | -65.45 | -43.16 | |
| Shares Outstanding (Basic) | 8 | 6 | 4 | 2 | 1 | |
| Shares Outstanding (Diluted) | 8 | 6 | 4 | 2 | 1 | |
| Shares Change (YoY) | 16.71% | 57.59% | 95.03% | 53.86% | 465.63% | |
| EPS (Basic) | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 | |
| EPS (Diluted) | -4.67 | -6.64 | -12.70 | -31.09 | -31.54 | |
| Free Cash Flow | -23.53 | -51.88 | -45.79 | -48.27 | -30.46 | |
| Free Cash Flow Per Share | -3.12 | -8.02 | -11.15 | -22.93 | -22.27 | |
| Gross Margin | 81.11% | 78.17% | 73.50% | 62.96% | 44.01% | |
| Operating Margin | -31.37% | -48.03% | -84.13% | -132.17% | -72.14% | |
| Profit Margin | -39.85% | -60.19% | -106.23% | -171.27% | -79.18% | |
| Free Cash Flow Margin | -26.59% | -72.74% | -93.28% | -126.32% | -55.89% | |
| EBITDA | -22.1 | -28.49 | -37.97 | -46.91 | -36.14 | |
| EBITDA Margin | -24.97% | -39.94% | -77.35% | -122.76% | -66.31% | |
| D&A For EBITDA | 5.67 | 5.77 | 3.33 | 3.6 | 3.18 | |
| EBIT | -27.77 | -34.26 | -41.3 | -50.51 | -39.32 | |
| EBIT Margin | -31.37% | -48.03% | -84.13% | -132.17% | -72.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.